Alexander Rosenstein - Cardiovascular Systems General Counsel and Corporate Secretary
| CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Executive
Mr. Alexander Rosenstein is General Counsel and Corporationrationrate Secretary of the Company. Mr. Rosenstein joined us in September 2014 as Corporationrationrate Legal and Compliance Counsel, became Corporationrationrate Secretary in November 2014, and was promoted to General Counsel in March 2015. From October 2005 to September 2014, Mr. Rosenstein was an attorney at Fredrikson Byron, P.A., which provides legal services to us from time to time, and from September 1998 to September 2005, he was an attorney practicing in New York City. since 2015.
| Age | 51 |
| Tenure | 9 years |
| Phone | 651 259 1600 |
| Web | https://www.csi360.com |
Cardiovascular Systems Management Efficiency
The company has return on total asset (ROA) of (0.0756) % which means that it has lost $0.0756 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1518) %, meaning that it created substantial loss on money invested by shareholders. Cardiovascular Systems' management efficiency ratios could be used to measure how well Cardiovascular Systems manages its routine affairs as well as how well it operates its assets and liabilities.Cardiovascular Systems currently holds 22.15 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Cardiovascular Systems has a current ratio of 5.93, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cardiovascular Systems' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Leah Akin | Neuropace | N/A | |
| Marc Nash | Outset Medical | 35 | |
| Karen Silva | Inari Medical | N/A | |
| Richard Glaze | CONMED | 58 | |
| Irene Thomas | Neuropace | 55 | |
| Sarah Meeks | MaxCyte | N/A | |
| Nathan Minnich | Treace Medical Concepts | N/A | |
| Alex CMA | LivaNova PLC | 54 | |
| John CFA | Inari Medical | N/A | |
| Brent JD | Bruker | 49 | |
| Shana MBA | Nevro Corp | 51 | |
| Brian Strauss | Inari Medical | N/A | |
| Jill Mason | Orthofix Medical | N/A | |
| Kimberly Lockwood | CONMED | N/A | |
| Jill Mayer | MaxCyte | N/A | |
| Daniel JD | Orthopediatrics Corp | 54 | |
| Angeline McCabe | Nevro Corp | N/A | |
| Matthew Millard | Paragon 28 | N/A | |
| Robert John | CVRx Inc | N/A | |
| Dan Yarbrough | Orthofix Medical | N/A | |
| Tonya SPHR | CVRx Inc | 52 | |
Management Performance
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 |
Cardiovascular Systems Leadership Team
Elected by the shareholders, the Cardiovascular Systems' board of directors comprises two types of representatives: Cardiovascular Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cardiovascular. The board's role is to monitor Cardiovascular Systems' management team and ensure that shareholders' interests are well served. Cardiovascular Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cardiovascular Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Philip Freed, VP Marketing | ||
| Stephen Rempe, Chief Officer | ||
| Jeffrey MD, Chief Officer | ||
| Peter Hirshman, VP Operations | ||
| Sandra Sedo, Chief Compliance Officer | ||
| Jeffrey Points, Chief Officer | ||
| BSc MS, Pres Chairman | ||
| Alexander Rosenstein, General Counsel and Corporate Secretary | ||
| John Nielsen, VP Communications |
Cardiovascular Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cardiovascular Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | |||
| Return On Asset | -0.0756 | |||
| Profit Margin | (0.16) % | |||
| Operating Margin | (0.16) % | |||
| Current Valuation | 466.13 M | |||
| Shares Outstanding | 42.2 M | |||
| Shares Owned By Insiders | 3.22 % | |||
| Shares Owned By Institutions | 89.64 % | |||
| Number Of Shares Shorted | 1.74 M | |||
| Price To Earning | 724.24 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |